Treatment success rate for patients treated for MDR-TB in Kyrgyzstan
Kyrgyzstan: Treatment success rate for patients treated for MDR-TB was 75.0% in 2022. ▲ Rising
Latest (2022)
75.0%
Change on year
unchanged
World rank
70th
of 163 countries
All-time high
75.0%
in 2021
All-time low
35.0%
in 2009
Years of data
17
2006–2022
Treatment success rate for patients treated for MDR-TB in Kyrgyzstan, 2006–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate for patients treated for mdr-tb in Kyrgyzstan is 75.0%, measured in 2022. That is the highest value across all 17 years on record.
That represents a change of up 19.0% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Kyrgyzstan peaked at 75.0% in 2021 and was at its lowest, 35.0%, in 2009.
Kyrgyzstan ranks 70th of 163 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 17 years of available data.
Treatment success rate for patients treated for MDR-TB in Kyrgyzstan, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 48.0% | — |
| 2007 | 50.0% | +4.2% |
| 2008 | 50.0% | +0.0% |
| 2009 | 35.0% | -30.0% |
| 2010 | 42.0% | +20.0% |
| 2011 | 57.0% | +35.7% |
| 2012 | 63.0% | +10.5% |
| 2013 | 57.0% | -9.5% |
| 2014 | 56.0% | -1.8% |
| 2015 | 54.0% | -3.6% |
| 2016 | 53.0% | -1.9% |
| 2017 | 55.0% | +3.8% |
| 2018 | 62.0% | +12.7% |
| 2019 | 72.0% | +16.1% |
| 2020 | 72.0% | +0.0% |
| 2021 | 75.0% | +4.2% |
| 2022 | 75.0% | +0.0% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 75.0% is below the median for lower middle income countries, which is 76.0%, 99% of the median. (43 countries reporting)
- Kyrgyzstan's 75.0% is above the median for Europe & Central Asia, which is 68.0%, 1.1× the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.8% | 35.0% | 50.0% | 4 |
| 2010s | 57.1% | 42.0% | 72.0% | 10 |
| 2020s | 74.0% | 72.0% | 75.0% | 3 |
Countries ranked near Kyrgyzstan
- 70 Mexico 75.0% compare
- 70 Côte d'Ivoire 75.0% compare
- 70 Sierra Leone 75.0% compare
- 70 Benin 75.0% compare
- 70 North Macedonia 75.0% compare
- 70 Myanmar 75.0% compare
- 70 Yemen 75.0% compare
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Kyrgyzstan?
- Treatment success rate for patients treated for mdr-tb in Kyrgyzstan was 75.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Kyrgyzstan?
- The highest recorded value was 75.0% in 2021.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Kyrgyzstan?
- The lowest recorded value was 35.0% in 2009.
- How does Kyrgyzstan rank for treatment success rate for patients treated for mdr-tb?
- Kyrgyzstan ranks 70th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Kyrgyzstan?
- Over the last ten years it is up 19.0%. The long-run trend across the full record is rising.
- Where does this Kyrgyzstan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).